These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 15087386

  • 1. Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate.
    Furuhashi M, Sjöblom T, Abramsson A, Ellingsen J, Micke P, Li H, Bergsten-Folestad E, Eriksson U, Heuchel R, Betsholtz C, Heldin CH, Ostman A.
    Cancer Res; 2004 Apr 15; 64(8):2725-33. PubMed ID: 15087386
    [Abstract] [Full Text] [Related]

  • 2. Platelet-derived growth factor receptor-beta, carrying the activating mutation D849N, accelerates the establishment of B16 melanoma.
    Suzuki S, Heldin CH, Heuchel RL.
    BMC Cancer; 2007 Dec 12; 7():224. PubMed ID: 18076756
    [Abstract] [Full Text] [Related]

  • 3. The effects of tumor-derived platelet-derived growth factor on vascular morphology and function in vivo revealed by susceptibility MRI.
    Robinson SP, Ludwig C, Paulsson J, Ostman A.
    Int J Cancer; 2008 Apr 01; 122(7):1548-56. PubMed ID: 18033683
    [Abstract] [Full Text] [Related]

  • 4. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling.
    Hasumi Y, Kłosowska-Wardega A, Furuhashi M, Ostman A, Heldin CH, Hellberg C.
    Int J Cancer; 2007 Dec 15; 121(12):2606-14. PubMed ID: 17691110
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis.
    Song N, Huang Y, Shi H, Yuan S, Ding Y, Song X, Fu Y, Luo Y.
    Cancer Res; 2009 Aug 01; 69(15):6057-64. PubMed ID: 19584297
    [Abstract] [Full Text] [Related]

  • 6. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment.
    Guo P, Hu B, Gu W, Xu L, Wang D, Huang HJ, Cavenee WK, Cheng SY.
    Am J Pathol; 2003 Apr 01; 162(4):1083-93. PubMed ID: 12651601
    [Abstract] [Full Text] [Related]

  • 7. Specific targeting of PDGFRβ in the stroma inhibits growth and angiogenesis in tumors with high PDGF-BB expression.
    Tsioumpekou M, Cunha SI, Ma H, Åhgren A, Cedervall J, Olsson AK, Heldin CH, Lennartsson J.
    Theranostics; 2020 Apr 01; 10(3):1122-1135. PubMed ID: 31938055
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content.
    McCarty MF, Somcio RJ, Stoeltzing O, Wey J, Fan F, Liu W, Bucana C, Ellis LM.
    J Clin Invest; 2007 Aug 01; 117(8):2114-22. PubMed ID: 17641778
    [Abstract] [Full Text] [Related]

  • 9. Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development.
    Abramsson A, Kurup S, Busse M, Yamada S, Lindblom P, Schallmeiner E, Stenzel D, Sauvaget D, Ledin J, Ringvall M, Landegren U, Kjellén L, Bondjers G, Li JP, Lindahl U, Spillmann D, Betsholtz C, Gerhardt H.
    Genes Dev; 2007 Feb 01; 21(3):316-31. PubMed ID: 17289920
    [Abstract] [Full Text] [Related]

  • 10. Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization.
    Stratman AN, Schwindt AE, Malotte KM, Davis GE.
    Blood; 2010 Nov 25; 116(22):4720-30. PubMed ID: 20739660
    [Abstract] [Full Text] [Related]

  • 11. Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor.
    Reddy K, Zhou Z, Jia SF, Lee TH, Morales-Arias J, Cao Y, Kleinerman ES.
    Int J Cancer; 2008 Aug 15; 123(4):831-7. PubMed ID: 18537159
    [Abstract] [Full Text] [Related]

  • 12. Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts.
    Anderberg C, Li H, Fredriksson L, Andrae J, Betsholtz C, Li X, Eriksson U, Pietras K.
    Cancer Res; 2009 Jan 01; 69(1):369-78. PubMed ID: 19118022
    [Abstract] [Full Text] [Related]

  • 13. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.
    Benjamin LE, Hemo I, Keshet E.
    Development; 1998 May 01; 125(9):1591-8. PubMed ID: 9521897
    [Abstract] [Full Text] [Related]

  • 14. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors.
    Battegay EJ, Rupp J, Iruela-Arispe L, Sage EH, Pech M.
    J Cell Biol; 1994 May 01; 125(4):917-28. PubMed ID: 7514607
    [Abstract] [Full Text] [Related]

  • 15. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis.
    Nissen LJ, Cao R, Hedlund EM, Wang Z, Zhao X, Wetterskog D, Funa K, Bråkenhielm E, Cao Y.
    J Clin Invest; 2007 Oct 01; 117(10):2766-77. PubMed ID: 17909625
    [Abstract] [Full Text] [Related]

  • 16. Olfactomedin-like 3 promotes PDGF-dependent pericyte proliferation and migration during embryonic blood vessel formation.
    Imhof BA, Ballet R, Hammel P, Jemelin S, Garrido-Urbani S, Ikeya M, Matthes T, Miljkovic-Licina M.
    FASEB J; 2020 Nov 01; 34(11):15559-15576. PubMed ID: 32997357
    [Abstract] [Full Text] [Related]

  • 17. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
    Waltenberger J, Uecker A, Kroll J, Frank H, Mayr U, Bjorge JD, Fujita D, Gazit A, Hombach V, Levitzki A, Böhmer FD.
    Circ Res; 1999 Jul 09; 85(1):12-22. PubMed ID: 10400906
    [Abstract] [Full Text] [Related]

  • 18. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors.
    Abramsson A, Lindblom P, Betsholtz C.
    J Clin Invest; 2003 Oct 09; 112(8):1142-51. PubMed ID: 14561699
    [Abstract] [Full Text] [Related]

  • 19. Growth factor PDGF-B/v-sis confers a tumorigenic phenotype to human tumor cells bearing PDGF receptors but not to cells devoid of receptors: evidence for an autocrine, but not a paracrine, mechanism.
    Potapova O, Fakhrai H, Mercola D.
    Int J Cancer; 1996 May 29; 66(5):669-77. PubMed ID: 8647631
    [Abstract] [Full Text] [Related]

  • 20. Functional analysis of aortic endothelial cells expressing mutant PDGF receptors with respect to expression of matrix metalloproteinase-3.
    Kanaki T, Bujo H, Mori S, Yanjuan Z, Takahashi K, Yokote K, Morisaki N, Saito Y.
    Biochem Biophys Res Commun; 2002 Jun 07; 294(2):231-7. PubMed ID: 12051699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.